Vasileios Tsagkalidis
Overview
Explore the profile of Vasileios Tsagkalidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsagkalidis V, Ecker B
Ann Surg Oncol
. 2024 Apr;
31(7):4240-4241.
PMID: 38622457
No abstract available.
2.
Tsagkalidis V, Choe J, Beninato T, Eskander M, Grandhi M, In H, et al.
Ann Surg Oncol
. 2024 Apr;
31(7):4203-4212.
PMID: 38594579
Background: Mucinous appendiceal adenocarcinomas (MAA) and non-mucinous appendiceal adenocarcinomas (NMAA) demonstrate differences in rates and patterns of recurrence, which may inform the appropriate extent of surgical resection (i.e., appendectomy versus...
3.
Tsagkalidis V, Langan R, Ecker B
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136318
Ampullary carcinomas represent less than 1% of all gastrointestinal malignancies with an incidence of approximately 6 cases per 1 million. Histologic examination and immunohistochemistry have been traditionally used to categorize...
4.
Sok C, Ajay P, Tsagkalidis V, Kooby D, Shah M
Ann Surg Oncol
. 2023 Dec;
31(3):1509-1518.
PMID: 38062290
Gastric neuroendocrine tumors (G-NET) are rare tumors arising from enterochromaffin-like cells of the gastric mucosa. They belong to a larger group called gastroenteropancreatic neuroendocrine tumors and are classified as low,...
5.
Tsagkalidis V, Blaszczyk M, In H
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509323
Gastric cancer is among the top five causes of cancer-related death worldwide. Preoperative chemotherapy has been established as an option in patients with locally advanced gastric cancer. However, chemotherapy yields...
6.
Melucci A, Chacon A, Burchard P, Tsagkalidis V, Casabianca A, Goyal S, et al.
Ann Surg Oncol
. 2022 Sep;
29(13):8536-8547.
PMID: 36121582
Background: Carbohydrate antigen (CA) 19-9 is a biomarker to monitor treatment effect. A threshold to predict prognostic significance remains undefined. We evaluated the impact of CA19-9 on overall survival (OS)...
7.
Ajay P, Tsagkalidis V, Casabianca A, Burchard P, Melucci A, Chacon A, et al.
J Surg Oncol
. 2022 Aug;
126(8):1423-1429.
PMID: 35975699
Background: Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of unknown etiology and unpredictable natural history. To date, no large-scale studies have been published evaluating this disease due to...
8.
Casabianca A, Tsagkalidis V, Burchard P, Chacon A, Melucci A, Reitz A, et al.
Eur J Surg Oncol
. 2022 Jun;
48(12):2448-2454.
PMID: 35773092
Background: Gallbladder cancer (GBC) is the most common biliary malignancy frequently metastatic at diagnosis with poor prognosis. While surgery remains the standard for early-stage GBC, the role of surgery in...